已收盘 09-25 16:00:00 美东时间
-0.120
-1.40%
今日重点评级关注:康托·菲茨杰拉德:维持Ultragenyx Pharmaceutical"超配"评级,目标价从96美元升至103美元;Canaccord Genuity:维持Ultragenyx Pharmaceutical"买入"评级,目标价从81美元升至83美元
08-21 11:40
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Keefe, Bruyette & Woods analyst Meyer Shields downgraded Allstate Corp (NYSE:ALL) from Market Per...
08-21 00:01
Top Wall Street analysts changed their outlook on these top names. For a comple...
08-21 00:01
Morgan Stanley analyst Cesar Medina downgrades Liberty Latin America (NASDAQ:LILA) from Equal-Weight to Underweight and maintains the price target from $7 to $7.
08-20 18:30
Liberty Latin America Ltd. Class A涨10.76%,报8.13美元
07-20 08:00
航天巨头DPC上市首周飙涨46%!黑莓业绩大超预期,上调全年营收展望,股价周涨36%;艾伯维斥资109亿美元收购APGE>>
06-27 12:00
Shares of La-Z-Boy Inc (NYSE:LZB) rose sharply in pre-market trading after the company after the company reported better-than-expected fourth-quarter financial results and announced a $300 million share buyback. EPS for the quarter for La-Z-Boy in the fourth quarter came in at $1.26, crushing the an...
06-17 16:42
Liberty Latin America Ltd. ("Liberty Latin America") (NASDAQ:LILA, OTC Link: LILAB))) today announced that its Liberty Puerto Rico subsidiary has successfully entered into two new financing agreements through existing
06-01 20:10
Holders of the Series A Preference Shares are entitled to receive quarterly cash dividends at a rate of 9.0% per annum on a cumulative basis, commencing on September 15, 2026, and thereafter on each dividend payment
05-21 21:12
Liberty Latin America (NASDAQ:LILA) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.03) by 266.67 percent. This is a 84.06 percent increase over losses of $(0.69) per
05-07 19:09